Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$11.5M |
| 2 |
Eli Lilly
LLY
|
+$10.9M |
| 3 |
UnitedHealth
UNH
|
+$9.37M |
| 4 |
HOLX
Hologic
HOLX
|
+$8.36M |
| 5 |
AbbVie
ABBV
|
+$7.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$14.1M |
| 2 |
Dell
DELL
|
+$10.7M |
| 3 |
Molson Coors Class B
TAP
|
+$9.81M |
| 4 |
Netflix
NFLX
|
+$8.78M |
| 5 |
Bank of N.T. Butterfield & Son
NTB
|
+$8.31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.58% |
| 2 | Consumer Discretionary | 15.85% |
| 3 | Technology | 13.94% |
| 4 | Communication Services | 9.51% |
| 5 | Financials | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
VanEck Oil Services ETF
OIH
$1.95B
| – | – |
-394
| Closed | -$230K |
|
627
Oil States International
OIS
$522M
| – | – |
-16,184
| Closed | -$510K |
|
628
Oracle
ORCL
$422B
| – | – |
-74,426
| Closed | -$2.92M |
|
629
Old Republic International
ORI
$10B
| – | – |
-10,259
| Closed | -$181K |
|
630
Oshkosh
OSK
$9.7B
| – | – |
-10,107
| Closed | -$566K |
|
631
Puma Biotechnology
PBYI
$477M
| – | – |
-18,596
| Closed | -$1.25M |
|
632
Procter & Gamble
PG
$336B
| – | – |
-17,661
| Closed | -$1.58M |
|
633
Philip Morris
PM
$293B
| – | – |
-14,001
| Closed | -$1.36M |
|
634
PNC Financial Services
PNC
$97B
| – | – |
-2,327
| Closed | -$209K |
|
635
PTC Therapeutics
PTCT
$5.83B
| – | – |
-54,605
| Closed | -$765K |
|
636
Rio Tinto
RIO
$171B
| – | – |
-10,940
| Closed | -$365K |
|
637
RTX Corp
RTX
$283B
| – | – |
-28,575
| Closed | -$1.83M |
|
|
SAGE
638
DELISTED
Sage Therapeutics
SAGE
| – | – |
-30,567
| Closed | -$1.41M |
|
|
SCHW
639
Charles Schwab
SCHW
$194B
| – | – |
-10,334
| Closed | -$326K |
|
|
SF
640
Stifel
SF
$12.2B
| – | – |
-34,193
| Closed | -$584K |
|
641
Synopsys
SNPS
$76.2B
| – | – |
-12,170
| Closed | -$722K |
|
642
State Street SPDR S&P 500 ETF Trust
SPY
$809B
| – | – |
-1,700
| Closed | -$368K |
|
643
Stagwell
STGW
$2.13B
| – | – |
-44,753
| Closed | -$479K |
|
644
Seagate
STX
$193B
| – | – |
-9,857
| Closed | -$380K |
|
645
Stanley Black & Decker
SWK
$15.1B
| – | – |
-4,070
| Closed | -$501K |
|
646
Skyworks Solutions
SWKS
$10.1B
| – | – |
-41,483
| Closed | -$3.16M |
|
647
Synchrony
SYF
$25.9B
| – | – |
-46,209
| Closed | -$1.29M |
|
648
Trip.com Group
TCOM
$29B
| – | – |
-15,102
| Closed | -$704K |
|
649
Teva Pharmaceuticals
TEVA
$43.5B
| – | – |
-23,862
| Closed | -$1.1M |
|
650
Teleflex
TFX
$5.88B
| – | – |
-7,516
| Closed | -$1.26M |
|
Similar funds
Steve Schonfeld's Q4 2016 Portfolio in Review
As of Q4 2016, Steve Schonfeld held 720 positions worth $772M, up 31% from $589M the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Steve Schonfeld deployed $177M of net new capital in Q4 2016, opening 321 new positions and adding to 119 existing holdings. Its largest new stake was Eli Lilly: 146,398 shares worth $10.8M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Amazon, an estimated $14.1M trimmed.
- Steve Schonfeld's largest Q4 2016 buy was Eli Lilly: 146,398 shares worth $10.8M.
- Steve Schonfeld added most to Amgen in Q4 2016, an estimated $11.5M increase.
- Steve Schonfeld's biggest Q4 2016 reduction was Amazon, cutting an estimated $14.1M.
- Steve Schonfeld fully exited Bank of N.T. Butterfield & Son in Q4 2016, selling an estimated $8.31M.
- Steve Schonfeld's ten largest holdings make up 12% of its $772M portfolio in Q4 2016.
- Steve Schonfeld opened 321 new positions and closed 193 in Q4 2016.
- Steve Schonfeld's portfolio value rose 31% quarter-over-quarter to $772M.
Based on Schonfeld Strategic Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.